Cost Effectiveness of the Prevention and Treatment of Deep Vein Thrombosis and Pulmonary Embolism

This publication has 37 references indexed in Scilit:

• Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
  New England Journal of Medicine, 1995
• Economic evaluation of standard heparin and enoxaparin for prophylaxis against deep vein thrombosis in elective hip surgery
  British Journal of Surgery, 1994
• Epidemiology and natural history of venous thromboembolism
  Progress in Cardiovascular Diseases, 1994
• Cost/ Benefit Aspects on Thromboprophylaxis
  Pathophysiology of Haemostasis and Thrombosis, 1993
• Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
  The Lancet, 1992
• Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis
  New England Journal of Medicine, 1990
• Two Strategies For Prophylaxis of Fatal Postoperative Pulmonary Embolism
  International Journal of Technology Assessment in Health Care, 1990
• Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
  New England Journal of Medicine, 1988
• Heparin and the In-Hospital Management of Deep Venous Thrombosis: Cost Considerations
  Mayo Clinic Proceedings, 1986
• Prophylaxis of Venous Thromboembolism
  Annals of Surgery, 1980